Table 3.
Electrode locations for all patients by thalamic nuclei and regions
| Electrodes implanted (n) | Detection | Stimulation | |||
| Initial | At MRF | Initial | At MRF | ||
| CM | 10 | 80% (8) | 50% (5) | 50% (5) | 70% (7) |
| Po | 2 | 100% (2) | 100% (2) | 100% (2) | 100% (2) |
| PuA | 1 | 100% (1) | 0% (0) | 0% (0) | 0% (0) |
| VLpd | 2 | 0% (0) | 50% (1) | 100% (2) | 100% (2) |
| VLpv | 3 | 67% (2) | 67% (2) | 67% (2) | 67% (2) |
| VPLa | 1 | 0% (0) | 0% (0) | 0% (0) | 0% (0) |
| VPLp | 4 | 50% (2) | 75% (3) | 75% (3) | 75% (3) |
| VPM | 4 | 25% (1) | 25% (1) | 25% (1) | 25% (1) |
| WM | 5 | 0% (0) | 20% (1) | 20% (1) | 20% (1) |
Total number of electrodes implanted in a location, as well as percentage and number of electrodes used for detection and stimulation at initial programming and at MRFU.
CM, centromedian; MRFU, most recent follow-up; Po, posterior; PuA, pulvinar anterior; VLpd, posterior dorsal ventral lateral; VLpv, posterior ventral ventral lateral; VPLa, anterior ventral posterior lateral; VPLp, posterior ventral posterior lateral; VPM, ventral posterior medial; WM, white matter.